
Medtronic renal denervation system wins approval in China
Medtronic (NYSE: MDT)+
today announced its Symplicity Spyral renal denervation system won National Medical Products Administration (NMPA) approval in China.
Medtronic (NYSE: MDT)+
today announced its Symplicity Spyral renal denervation system won National Medical Products Administration (NMPA) approval in China.
Owlet announced that it received CE mark approval for its Dream Sock device for monitoring the vital signs of infants.
WASHINGTON, May 2, 2024 /PRNewswire/ — MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the successful granting of Darmiyan’s De Novo request for BrainSee by the U.S. Food and Drug Administration (FDA).
Zirconia materials now qualified for use in the production of the world’s thinnest cosmetic veneers.
Approval grants EU providers access to crucial life-saving device, indicative of the company’s global growth and ability to increase emergency and trauma care.
MyKidneyAI Becomes the Company’s Second Innovation to Recently Receive this FDA Distinction
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system
Route 92 Medical today announced it received FDA 510(k) clearance for its FreeClimb 54 reperfusion system.
The FDA granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics (NYSE:SENS).
Abbott (NYSE: ABT)+
announced today that the FDA approved its Esprit everolimus-eluting resorbable scaffold system.